» Articles » PMID: 29309293

Orthopaedic Manifestations of Sickle Cell Disease

Overview
Publisher Wolters Kluwer
Date 2018 Jan 9
PMID 29309293
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle cell disease (SCD) is an autosomal recessive disorder that results in hemolytic anemia related to abnormal hemoglobin and erythrocyte levels. SCD is characterized by vascular occlusive episodes, visceral sequestration, and aplastic or hemolytic crises. These crises most commonly occur in bone. The orthopaedic manifestations of SCD comprise much of the morbidity associated with this disorder. Osteonecrosis and osteomyelitis are among the most disabling and serious musculoskeletal complications in patients with SCD. Effective management of the bone and joint sequelae requires an accurate diagnosis, an understanding of the pathophysiology of the disease, and knowledge of available medical and surgical treatment alternatives. The major orthopaedic manifestations of SCD are osteonecrosis, osteomyelitis, septic arthritis, and bone infarction. Patients with SCD require close monitoring in the perioperative period because of the risk for vasoocclusive crisis.

Citing Articles

Vitamin D Deficiency and Avascular Necrosis in Patients With Sickle Cell Disease: A Retrospective Cohort Study.

Tammas A, Albehlal L, Alabbas F Cureus. 2024; 16(10):e72269.

PMID: 39583381 PMC: 11585072. DOI: 10.7759/cureus.72269.


Indicators for Osteomyelitis in Children With Sickle Cell Disease Admitted With Vaso-Occlusive Crises.

Tashkandi D, Hanafy E, Alotaibi N, Abuharfel D, Alnijaidi A, Banjar A Cureus. 2024; 16(8):e68265.

PMID: 39238724 PMC: 11375391. DOI: 10.7759/cureus.68265.


Role of Traditional Stroke Risk Factors Aiding in Prediction of Infarcts in Adult Patients With Sickle Cell Disease.

Garelnabi M, Parinandi N J Am Heart Assoc. 2024; 13(12):e034798.

PMID: 38842295 PMC: 11255737. DOI: 10.1161/JAHA.124.034798.


Complete resolution of stage II avascular necrosis affecting three joints by hyperbaric oxygen in a patient with sickle cell disease: A case report.

Alshurafa A, Elhissi M, Yassin M Front Med (Lausanne). 2022; 9:1063255.

PMID: 36530906 PMC: 9748694. DOI: 10.3389/fmed.2022.1063255.


Is the treatment of inflammatory arthritis different in sickle cell disease?.

Kimyon G, Ilhan G Turk J Med Sci. 2022; 52(5):1721-1728.

PMID: 36422487 PMC: 10395667. DOI: 10.55730/1300-0144.5515.